PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-1.25
Negative P/E while Healthcare median is -1.25. Seth Klarman would scrutinize path to profitability versus peers.
14.90
P/S exceeding 1.5x Healthcare median of 7.49. Jim Chanos would check for potential multiple compression risks.
0.52
P/B less than half the Healthcare median of 1.91. Joel Greenblatt would investigate if assets are truly impaired. Check ROE versus peers.
-87.45
Negative FCF while Healthcare median P/FCF is -5.64. Seth Klarman would investigate cash flow improvement potential.
-111.28
Negative operating cash flow while Healthcare median P/OCF is -4.10. Seth Klarman would investigate operational improvement potential.
0.52
Fair value ratio less than half the Healthcare median of 1.92. Joel Greenblatt would investigate if this discount is justified.
-20.04%
Negative earnings while Healthcare median yield is -2.47%. Seth Klarman would investigate path to profitability.
-1.14%
Negative FCF while Healthcare median yield is -1.49%. Seth Klarman would investigate cash flow improvement potential.